Is It Too Late to Buy Novavax Stock?

Is It Too Late to Buy Novavax Stock?

This month, the U.S. government awarded Novavax (NASDAQ: NVAX) more funding than any other company in the coronavirus vaccine race. Operation Warp Speed, the government's effort to help bring a vaccine to market by January, awarded the biotech company $1.6 billion. The move surprised the market, as Novavax wasn't on the government's list of five companies to potentially receive funding.